Group One Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-82,700
Closed -$7.69M 9115
2021
Q4
$7.69M Buy
82,700
+31,000
+60% +$2.04M 0.01% 1329
2021
Q3
$3.08M Sell
51,700
-4,300
-8% -$254K ﹤0.01% 2215
2021
Q2
$3.82M Buy
56,000
+35,800
+177% +$2.33M ﹤0.01% 1960
2021
Q1
$1.4M Sell
20,200
-42,600
-68% -$3.28M ﹤0.01% 2841
2020
Q4
$4.83M Sell
62,800
-29,100
-32% -$2.18M 0.01% 1303
2020
Q3
$6.87M Buy
91,900
+41,000
+81% +$2.73M 0.02% 709
2020
Q2
$3.2M Buy
50,900
+13,100
+35% +$721K 0.01% 1123
2020
Q1
$1.59M Sell
37,800
-18,900
-33% -$867K 0.01% 1191
2019
Q4
$2.58M Sell
56,700
-3,200
-5% -$151K 0.02% 1101
2019
Q3
$2.74M Buy
59,900
+11,100
+23% +$624K 0.02% 970
2019
Q2
$2.86M Buy
48,800
+2,300
+5% +$119K 0.03% 846
2019
Q1
$2.08M Sell
46,500
-22,000
-32% -$1.01M 0.02% 907
2018
Q4
$2.67M Buy
68,500
+3,600
+6% +$141K 0.02% 841
2018
Q3
$2.99M Sell
64,900
-4,800
-7% -$195K 0.02% 884
2018
Q2
$3.04M Sell
69,700
-234,000
-77% -$10.1M 0.03% 828
2018
Q1
$12M Sell
303,700
-198,400
-40% -$7.72M 0.12% 169
2017
Q4
$17.1M Buy
502,100
+150,900
+43% +$4.3M 0.12% 176
2017
Q3
$8.96M Buy
351,200
+239,500
+214% +$5.49M 0.08% 292
2017
Q2
$1.88M Buy
111,700
+79,720
+249% +$1.09M 0.02% 990
2017
Q1
$467K Sell
31,980
-2,650
-8% -$39.3K 0.01% 1890
2016
Q4
$492K Buy
+34,630
New +$536K ﹤0.01% 1785
2013
Q3
Sell
-108,770
Closed -$8.38M 5722
2013
Q2
$8.38M Buy
+108,770
New +$8.88M 0.21% 86

Group One Trading's ARNA Position: Q1 2022 in Review

Group One Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 42,327 shares — an estimated $3.93M sold.

Group One Trading first reported a position in ARNA in Q3 2013 and held it in 24 quarters. The position peaked at $6.47M in Q3 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Group One Trading reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 42,327 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.93M.
  • Group One Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 24 quarters.
  • Group One Trading's Arena Pharmaceuticals Inc position peaked at $6.47M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.